Evaluation of the Efficacy of Methylene Blue Administration in SARS-CoV2-Affected Patients: a Phase 2, Randomized, Placebo-Controlled, Single Blind Clinical Trial (Ticino, Switzerland) (2020)

Government Record · Fondazione Epatocentro Ticino · 2020

Fondazione Epatocentro Ticino, 2020: Swiss phase 2 randomised placebo-controlled single-blind trial of methylene blue in 29 SARS-CoV-2 patients, completed, no results posted.

Despite enormous progress in understanding COVID-19, there is little evidence that a solution, therapeutic or preventive, is close to being achieved.

Registry record field

Fondazione Epatocentro Ticino, 2020: Swiss phase 2 randomised placebo-controlled single-blind trial of methylene blue in 29 SARS-CoV-2 patients, completed, no results posted. Study type: other.